Rapid Skeletal Muscle Loss in Cirrhosis: Predictors, Outcomes, and Implications for Clinical Management
Highlight
Median annual skeletal muscle loss in patients with cirrhosis awaiting liver transplantation is approximately 1.6%.
Rapid muscle loss (RML), defined as the worst quartile of muscle loss (< -7.4% per year), predicts significantly higher waitlist mortality independent of MELD-Na score.
Ascites and higher MELD-Na scores independently associate with increased risk of RML.
Understanding the rate of muscle loss and its predictors informs prognostication and potential interventions targeting sarcopenia in cirrhosis.
Study Background
Sign in free to continue reading
Create or use your MedXY account to unlock the complete article.
This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.